A team led by scientists at Georgia State University simulates the precise transition between the processes of DNA synthesis and proofreading
DNA replication is one of the most important processes in biology, responsible for ensuring that a cell’s genetic material is copied over to new cells efficiently during cell division. But what happens when there is a mistake?
Fortunately, replicative DNA polymerases—the cell’s replication molecular machines—are capable of proofreading the newly synthesized DNA and correcting mistakes made during the DNA replication process. These polymerases detect misincorporated DNA bases and transfer them to a specialized compartment inside of the polymerase to excise them.
If it weren’t for these versatile and efficient machines, the cell’s genetic material would be compromised, potentially leading to abnormal cellular functioning, impaired development, and diseases such as cancer. But just how mistakes are corrected while the polymerase synthesizes a new DNA strand hasn’t been fully understood.
Now, a team at Georgia State University has used the nation’s fastest supercomputer, the IBM AC922 Summit at the US Department of Energy’s (DOE’s) Oak Ridge National Laboratory (ORNL), to find the optimal transition path that a highly accurate bacterial DNA polymerase uses to switch between building and editing DNA. This optimal DNA path serves as a molecular highway, guiding the starting point of the DNA strand as it travels the large distance between the two sites where DNA is synthesized or excised. The work was published in the journal Nature Communications.
“We represented the path between these two—the polymerase and exonuclease states—as a series of replicas of the simulation system that were all optimized and sampled simultaneously,” said Ivaylo Ivanov, researcher at Georgia State University. “Applying path optimization methods to large macromolecular complexes was, until recently, computationally prohibitively expensive. Only with recent advances in GPU technology on massively parallel computing platforms like Summit did it become possible for us to sample the conformational ensemble along the optimal path.”
Image Credit: Ivaylo Ivanov, Georgia State University
When covid-19 struck Europe in March 2020, hospitals were plunged into a health crisis that was still badly understood. “Doctors really didn’t have a clue how to manage these patients,” says Laure Wynants, an [...]
Pfizer found to be 88 per cent effective at preventing symptomatic disease from delta variant. Two doses of Pfizer-BioNTech or AstraZeneca-Oxford's COVID-19 vaccines are nearly as effective against the highly transmissible delta coronavirus variant [...]
South African pharmaceutical company Aspen said Monday it was releasing its first batch of African-produced COVID-19 vaccines under a licensing deal with the US giant Johnson & Johnson. The Durban-based company said the first [...]
Since the coronavirus pandemic shut down the world, scientists have clamored to develop vaccines to prevent the spread and medicines that will cure the sick. But a virus’ main goal is to replicate and [...]
The highly transmissible delta variant of SARS-CoV-2, the coronavirus causing the disease COVID-19, is now present in 124 countries and will become the dominant strain globally in the coming months as it is outcompeting [...]
Scientists have backed proposals for Covid boosters in the autumn after blood tests on hundreds of people revealed that protective antibodies can wane substantially within weeks of second vaccine shots being given. Falls in [...]
Researchers in the United States have conducted a study showing that the coronavirus disease 2019 (COVID-19) vaccines developed by Pfizer-BioNTech and Moderna generate a coordinated adaptive immune response that is capable of eliciting recall [...]
CSIRO, Australia's national science agency, played an important role in evaluating heat-tolerant COVID-19 vaccine formulations developed by the Indian Institute of Science (IISc) and biotech start-up Mynvax—against all current SARS-CoV-2 variants of concern. Published [...]
Podcast – Nanovisaging 2040 How Synergies between Nanotechnology, Nanomedicine, and AI might Benefit Humanity
Frank Boehm (NanoApps Medical Inc. Founder) in discussion with Nana Kay in a Wealth Secrets podcast. EP 19. Nanovisaging 2040. From Nana Kay: Nanovisaging 2040: How Synergies between Nanotechnology, Nanomedicine, and AI might Benefit [...]
Canada, like several other countries, has been mixing and matching COVID-19 vaccines for weeks amid safety concerns over the AstraZeneca shot. On Monday, the chief scientist at the World Health Organization (WHO) cautioned against that approach, calling [...]
Scientists have harnessed CRISPR gene-editing technology to block the replication of the novel coronavirus in human cells — an approach that could one day serve as a new treatment for COVID-19. However, the study was performed [...]
A recent study by scientists from Japanese universities has shown that the shape of cell-derived nanoparticles, known as "extracellular vesicles" (EVs), in body fluids could be a biomarker for identifying types of cancer. In [...]
An important lesson for vaccine design Australian scientists researching how our immune system responds to COVID-19 have revealed that those infected by early variants in 2020 produced sustained antibodies, however, these antibodies are not [...]
1. How COVID-19 is affecting the globe Confirmed cases of COVID-19 have passed 185 million globally, according to Johns Hopkins University. The number of confirmed deaths stands at more than 4 million. More than 3.29 [...]
The World Health Organization (WHO) has added another COVID strain to its list of coronavirus variants to keep an eye on: the COVID-19 Lambda variant. This particular variant has now spread to more than two dozen [...]